Following the successful completion of preclinical development for their HemoSystem blood purification platform, hemotune closed a CHF 14 million Series B2 round. The funds will be used to move into clinical trials.
![CHF 14 million to fund hemotune’s clinical trials](https://republic-of-innovation.ch/wordpress/wp-content/uploads/2024/03/Hemotune.jpg)
Following the successful completion of preclinical development for their HemoSystem blood purification platform, hemotune closed a CHF 14 million Series B2 round. The funds will be used to move into clinical trials.